Skip to main content
Premium Trial:

Request an Annual Quote

Genzyme Gives Boston Museum of Science $2M for Biotechnology Education

NEW YORK, April 13 (GenomeWeb News) - Genzyme is contributing $2 million to the Museum of Science in Boston to support a biotechnology education initiative.


The company expects the Genzyme Biotechnology Education Initiative to include material related to genomics, proteomics, microarrays, and other new technogies, but discussions are only just beginning, a Genzyme spokesperson told GenomeWeb News today.


The initiative will include K-12 science and technology curricula, educational fora, professional development workshops for teachers, presentations for school groups, lectures, and web-based resources, as well as interactive exhibits at the Museum of Science, according to a statement from the organization.

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.